MTB
71
2
HSY
34
-3
BIIB
52
-4
ZBH
45
-2
PSX
40
-2
LMT
57
7
PYPL
49
-3
BRK.B
40
-3
ECL
50
-2
DHI
33
-6
CMCSA
39
7
IVZ
69
7
TMO
54
2
DUK
50
-2
TAP
37
8
SBUX
36
-4
NAVI
32
2
TSN
43
-3
LEN
36
-4
ETN
67
2
MTB
71
2
HSY
34
-3
BIIB
52
-4
ZBH
45
-2
PSX
40
-2
LMT
57
7
PYPL
49
-3
BRK.B
40
-3
ECL
50
-2
DHI
33
-6
CMCSA
39
7
IVZ
69
7
TMO
54
2
DUK
50
-2
TAP
37
8
SBUX
36
-4
NAVI
32
2
TSN
43
-3
LEN
36
-4
ETN
67
2
Financhill
Back

Matthews Asia Innovators Active ETF Vs. Kymera Therapeutics, Inc. Sector Stock Comparison

Buy
70

MINV
Matthews Asia Innovators Active ETF

Last Price:
$35.85
Seasonality Move:
10.59%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Buy
70
Matthews Asia Innovators Active ETF (MINV) is a Buy

Is Matthews Asia Innovators Active ETF a Buy, Sell or Hold?

  • The current Matthews Asia Innovators Active ETF [MINV] share price is $35.85. The Score for MINV is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • MINV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

MINV Stock Price Chart

What is Matthews Asia Innovators Active ETF's stock price today?

  • The Matthews Asia Innovators Active ETF share price today is $35.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MINV is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

MINV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 50.65 Buy
Chaikin Money Flow: -3755 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.05 - 36.45) Buy
Bollinger Bands (100): (33.63 - 37.13) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

MINV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.6 Buy
20-day SMA: 35.53 Buy
50-day SMA: 36.49 Sell
200-day SMA: 32.16 Buy
8-day EMA: 35.6 Buy
20-day EMA: 35.69 Buy
50-day EMA: 35.85 Sell
200-day EMA: 33.06 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

Matthews Asia Innovators Active ETF Earnings Growth & MINV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

Matthews Asia Innovators Active ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):